Nano-palladium is a cellular catalyst for in vivo chemistry - Wikidata - awgldk - TriplyDB

Nano-palladium is a cellular catalyst for in vivo chemistry

Nano-palladium is a cellular catalyst for in vivo chemistry

http://www.wikidata.org/entity/Q33903811

about

Catalytically Active Single-Chain Polymeric Nanoparticles: Exploring Their Functions in Complex Biological Media.A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging.A cell-penetrating artificial metalloenzyme regulates a gene switch in a designer mammalian cell.

P2860

Q49859378-9E3BB095-2987-4D42-A2BE-40D41F0A367D Q55034564-AF60BC51-CCB1-4182-8290-ADD3BE9BB724 Q55314912-5624082C-093F-464A-AD0A-C27115C30703

P2860

Nano-palladium is a cellular catalyst for in vivo chemistry

http://www.wikidata.org/entity/Q33903811

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Nano-palladium is a cellular catalyst for in vivo chemistry

@ast

Nano-palladium is a cellular catalyst for in vivo chemistry

@en

type

label

Nano-palladium is a cellular catalyst for in vivo chemistry

@ast

Nano-palladium is a cellular catalyst for in vivo chemistry

@en

prefLabel

Nano-palladium is a cellular catalyst for in vivo chemistry

@ast

Nano-palladium is a cellular catalyst for in vivo chemistry

@en

P1433

Q33903811-9CECB3BC-FA7E-4C82-83D1-00FA9E50708E

P1476

Q33903811-38A4913F-0BD1-49B1-A3C4-A8633F7080E6

P2093

Q33903811-7C771A4A-08C4-41F0-9DCB-BE14B2267D76

Q33903811-C13FFC59-76A3-47A3-AFAA-626B0185D7C4

Q33903811-DB0BEB29-5989-441F-8804-2D83A7CF1DB9

P2860

Q33903811-00DA85A2-6958-4926-903B-8AC313CEEF15

Q33903811-00E21D65-1B48-407B-8222-7BD99EA76F32

Q33903811-035FCCDB-9BD1-4C89-9D37-831128ADF77F

Q33903811-090172F1-1743-4FC7-B03D-F5521E7D32A4

Q33903811-0B7D6D8E-027E-4A44-A3C6-BE276297CFF4

Q33903811-0D11EF4D-B85D-4DA9-B733-252B1781EAF4

Q33903811-348ECCE4-B2BA-403C-9336-42C32C01A623

Q33903811-34F7313C-5450-48B9-8452-7FB11EF47778

Q33903811-3726AA9A-0C3C-433E-8992-7A9D0ACC9742

Q33903811-3781AC49-31DE-403C-A1BF-F99839CD3831

P2888

Q33903811-31D1DA50-06ED-4575-B9E8-D4F576311C99

P304

Q33903811-68852975-FBCC-4535-9419-C1D8C455BA1E

P31

Q33903811-25704B21-978D-413E-8725-960523849E08

P356

Q33903811-8D5D7379-C0F8-4441-9970-AD301BD8A411

P407

Q33903811-13800314-8654-4F31-AE94-BEC3DD4B7DE4

P478

Q33903811-40DF0B31-39FC-4B02-BABB-523A69B3EC96

P50

Q33903811-5B0BD761-6D09-4592-86DA-1E5014349F91

Q33903811-61079C64-699B-446B-9EF4-F5E97C556C81

Q33903811-AA9E25A2-25D3-491B-9223-7F3FBFC7EF8A

P577

Q33903811-CE9A5188-6872-4FDB-A192-0CF49BA409EA

P6179

Q33903811-88887DD2-8A95-4513-9367-BCB6EF2144E8

P698

Q33903811-B31C80F8-1B99-4CDE-8C2A-B93374D98992

P932

Q33903811-A4E8DE9A-38D0-42AC-9B86-F166CA57B2E4

P356

P1433

Nature Communications

P1476

Nano-palladium is a cellular catalyst for in vivo chemistry

@en

P2093

Bjorn Askevold

http://www.w3.org/2001/XMLSchema#string

David Pirovich

http://www.w3.org/2001/XMLSchema#string

Miles A Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Polymeric nanoparticles for targeted treatment in oncology: current insights

Microbial engineering for the production of advanced biofuels

Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.

Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.

Palladium-mediated dealkylation of N-propargyl-floxuridine as a bioorthogonal oxygen-independent prodrug strategy

Single cell resolution in vivo imaging of DNA damage following PARP inhibition

Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.

P2888

P304

15906

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS15906

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Rainer H Kohler

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090612760

http://www.w3.org/2001/XMLSchema#string

P698

28699627

http://www.w3.org/2001/XMLSchema#string

P932

5510178

http://www.w3.org/2001/XMLSchema#string